Military doctrine for the planning and execution of U.S. counterdrug operations, including detection, monitoring, disruption and interdiction of illegal drug trafficking, is presented in a new publication from the Joint Chiefs of Staff. See “Joint Counterdrug Operations” (pdf), Joint Publication JP 3-07.4, 13 June 2007.
The “capstone” publication for all joint military doctrine was also recently updated and reissued. See Joint Publication JP 1, “Doctrine for the Armed Forces of the United States” (pdf), 14 May 2007.
DNA synthesis and export controls remain the primary regulatory safeguards against de novo production of harmful biological agents, yet governance frameworks lack the situational awareness and enforcement capacity to keep pace with rapidly falling technical barriers.
Called today to speak on behalf of U.S. science and technology, Dr. Jedidah Isler, astrophysicist, educator, strategist, policy-maker, and science communicator, will provide constructive, nonpartisan feedback to the House Committee’s hearing “American Global Competitiveness at 250: Legislative Proposals to Secure U.S. Technology Leadership.”
“Federal data and access to it is not a partisan issue. It is a people issue. Our country cannot achieve greatness without access to the data that measure what we value, who we are, and where we’re heading.”
The United States’ biosecurity governance system is structurally incapable of detecting and responding to certain classes of threats. U.S. biosecurity tools have not kept pace with technological advancements or a changing threat landscape.